In the infantile form, symptoms begin prior to 1 year of age after a period of normal early development. Early signs and symptoms of infantile Krabbe disease include irritability, hand fisting, and failure to thrive. A peripheral neuropathy may be present. Infants begin to regress developmentally and develop decorticate posturing with opisthotonus and sluggish pupillary reactions to light. The disease is relentlessly progressive, with development of blindness, deafness, and epilepsy, followed by death by 2 years.
In the later-onset form, symptoms begin after 1 year of age. The clinical course is more variable than that of the infantile form. However, symptoms typically occur between 1 and 3 years of age, after a period of normal development. Early signs and symptoms can include loss of developmental milestones, vision loss, gait changes, and seizures. The disease is more slowly progressive, and death typically occurs 4-6 years after symptom onset. In rare cases, symptom onset may not occur until later in childhood, adolescence, or adulthood.
Krabbe disease is rare, occurring in approximately 1:250 000 births in the United States. However, the incidence of disease varies among countries. For example, there is a high carrier rate in northern Israel and near Jerusalem.
E75.23 – Krabbe disease
192782005 – Galactosylceramide beta-galactosidase deficiency
- Metachromatic leukodystrophy
- Gaucher disease
- Niemann-Pick disease
- Tay-Sachs disease
- Sandhoff disease
- Pelizaeus-Merzbacher disease
- Canavan disease
- Saposin A deficiency
- Alexander disease
- Vanishing white matter disease
- Neuronal ceroid lipofuscinoses
- Acute demyelinating encephalomyelitis
- Anti-NMDA receptor encephalitis
- Central nervous system (CNS) infection, eg, progressive multifocal leukoencephalopathy
- Brain tumor, eg, glioblastoma, CNS lymphoma